Patent Assignment
Reel/Frame 059737/0613
Assignment of Assignor's Interest
Recorded: 2022-04-26
Pages: 7
Assignors
JAEGER, CARLA A.
Executed: 2020-12-01
CORRENTI, COLIN
Executed: 2020-12-01
RIDDELL, STANLEY R.
Executed: 2020-11-17
Assignee
FRED HUTCHINSON CANCER RESEARCH CENTER
1100 FAIRVIEW AVENUE NORTH, SEATTLE, WASHINGTON, 98109
Covered Property
(1)
Engineered Trimeric CD70 Proteins and Uses Thereof
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 26, 2022
From: JAEGER, CARLA A.; CORRENTI, COLIN E.
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 059737/0620 →
Assignment of Assignor's Interest
Apr 26, 2022
From: RIDDELL, STANLEY R.
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 059737/0635 →
Assignment of Assignor's Interest
Apr 26, 2022
From: JAEGER, CARLA A.; CORRENTI, COLIN E.; RIDDELL, STANLEY R.
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 059737/0639 →
Assignment of Assignor's Interest
Apr 26, 2022
From: JAEGER, CARLA A.; CORRENTI, COLIN E.; RIDDELL, STANLEY R.
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 059737/0646 →
Merger and Change of Name
Jun 23, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 060439/0279 →
Corrective Assignment to Correct the Patent Application Number 63/242,906 Previously Recorded on Reel 060439 Frame 0279. Assignor(S) Hereby Confirms the Merger and Change of Name.
Nov 4, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 061847/0594 →